Probiotics and Disease: A Comprehensive Summary-Part 4, Infectious Diseases

Overview

Journal Integr Med (Encinitas)

Specialty Rehabilitation Medicine

Date 2019 Mar 19

PMID 30881235

Authors

Margaret G Gasta

Christy B Williamson

Crystal M Gossard

Jessica M Pizano

Cathleen M Burns

Keren E Dolan

Heather J Finley

Emily C Parker

Elizabeth A Lipski

Affiliations

Soon will be listed here.

Abstract

This article series provides a literature review of the disease-specific probiotic strains studied in published clinical trials in humans and animals. The goal of the series is to provide clinically useful tools. The table design allows for quick access to supportive data and will be helpful as a guide for both researchers and clinicians. The first article (part 1) focused on mental health and neurological conditions and the second article (part 2) explored cultured and fermented foods that are commonly available in the United States. The third article (part 3) explored the relationship between bacterial strains and 2 of the most prevalent diseases we have in modern society, cardiometabolic disease and fatigue syndromes. This fourth article (part 4) elucidates the role of the microbiome in infectious diseases. Future articles will review conditions related to infections of the upper respiratory system and ear, nose, and throat; autoimmunity and dermatological conditions; cancer; and gastrointestinal and genitourinary, followed by an article focused on probiotic supplements. This literature review is specific to disease condition, probiotic classification, and individual strain.

References

Loguercio C, De Simone T, Federico A, Terracciano F, Tuccillo C, Di Chicco M . Gut-liver axis: a new point of attack to treat chronic liver damage?. Am J Gastroenterol. 2002; 97(8):2144-6. DOI: 10.1111/j.1572-0241.2002.05942.x. View

Riordan S, Skinner N, Nagree A, McCallum H, McIver C, Kurtovic J . Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis. Hepatology. 2003; 37(5):1154-64. DOI: 10.1053/jhep.2003.50180. View

Salminen M, Tynkkynen S, Rautelin H, Poussa T, Saxelin M, Ristola M . The efficacy and safety of probiotic Lactobacillus rhamnosus GG on prolonged, noninfectious diarrhea in HIV Patients on antiretroviral therapy: a randomized, placebo-controlled, crossover study. HIV Clin Trials. 2004; 5(4):183-91. DOI: 10.1310/6F83-N39Q-9PPP-LMVV. View

Zhao H, Wang H, Lu Z, Xu S . Intestinal microflora in patients with liver cirrhosis. Chin J Dig Dis. 2004; 5(2):64-7. DOI: 10.1111/j.1443-9573.2004.00157.x. View

Smits H, Engering A, van der Kleij D, de Jong E, Schipper K, van Capel T . Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol. 2005; 115(6):1260-7. DOI: 10.1016/j.jaci.2005.03.036. View

Clancy R, Gleeson M, Cox A, Callister R, Dorrington M, Deste C . Reversal in fatigued athletes of a defect in interferon gamma secretion after administration of Lactobacillus acidophilus. Br J Sports Med. 2006; 40(4):351-4. PMC: 2577537. DOI: 10.1136/bjsm.2005.024364. View

Boyle R, Robins-Browne R, Tang M . Probiotic use in clinical practice: what are the risks?. Am J Clin Nutr. 2006; 83(6):1256-64. DOI: 10.1093/ajcn/83.6.1256. View

Anukam K, Osazuwa E, Osemene G, Ehigiagbe F, Bruce A, Reid G . Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes Infect. 2006; 8(12-13):2772-6. DOI: 10.1016/j.micinf.2006.08.008. View

Lam E, Tai E, Koo M, Wong H, Wu W, Yu L . Enhancement of gastric mucosal integrity by Lactobacillus rhamnosus GG. Life Sci. 2007; 80(23):2128-2136. DOI: 10.1016/j.lfs.2007.03.018. View

10.

Ewaschuk J, Endersby R, Thiel D, Diaz H, Backer J, Ma M . Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis. Hepatology. 2007; 46(3):841-50. DOI: 10.1002/hep.21750. View

11.

Trois L, Cardoso E, Miura E . Use of probiotics in HIV-infected children: a randomized double-blind controlled study. J Trop Pediatr. 2007; 54(1):19-24. DOI: 10.1093/tropej/fmm066. View

12.

Lata J, Novotny I, Pribramska V, Jurankova J, Fric P, Kroupa R . The effect of probiotics on gut flora, level of endotoxin and Child-Pugh score in cirrhotic patients: results of a double-blind randomized study. Eur J Gastroenterol Hepatol. 2007; 19(12):1111-3. DOI: 10.1097/MEG.0b013e3282efa40e. View

13.

Sanders M . Probiotics: definition, sources, selection, and uses. Clin Infect Dis. 2008; 46 Suppl 2:S58-61. DOI: 10.1086/523341. View

14.

Anukam K, Osazuwa E, Osadolor H, Bruce A, Reid G . Yogurt containing probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 helps resolve moderate diarrhea and increases CD4 count in HIV/AIDS patients. J Clin Gastroenterol. 2008; 42(3):239-43. DOI: 10.1097/MCG.0b013e31802c7465. View

15.

Rio B, Dattwyler R, Aroso M, Neves V, Meirelles L, Seegers J . Oral immunization with recombinant lactobacillus plantarum induces a protective immune response in mice with Lyme disease. Clin Vaccine Immunol. 2008; 15(9):1429-35. PMC: 2546682. DOI: 10.1128/CVI.00169-08. View

16.

Kirpich I, Solovieva N, Leikhter S, Shidakova N, Lebedeva O, Sidorov P . Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. Alcohol. 2008; 42(8):675-82. PMC: 2630703. DOI: 10.1016/j.alcohol.2008.08.006. View

17.

Martinez R, Franceschini S, Patta M, Quintana S, Candido R, Ferreira J . Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. Lett Appl Microbiol. 2009; 48(3):269-74. DOI: 10.1111/j.1472-765X.2008.02477.x. View

18.

Forsyth C, Farhadi A, Jakate S, Tang Y, Shaikh M, Keshavarzian A . Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis. Alcohol. 2009; 43(2):163-72. PMC: 2675276. DOI: 10.1016/j.alcohol.2008.12.009. View

19.

Resta-Lenert S, Barrett K . Modulation of intestinal barrier properties by probiotics: role in reversing colitis. Ann N Y Acad Sci. 2009; 1165:175-82. DOI: 10.1111/j.1749-6632.2009.04042.x. View

20.

Forrester J, Wang X, Knox T, Borek C, Tang A, Johnson E . Factors associated with serum retinol, alpha-tocopherol, carotenoids, and selenium in Hispanics with problems of HIV, chronic hepatitis C, and drug use. J Public Health Policy. 2009; 30(3):285-99. PMC: 2764270. DOI: 10.1057/jphp.2009.20. View